Abstract
Escherichia coli O157:H7 is the most common infectious cause of bloody diarrhea or hemorrhagic colitis (HC) in the United States (1). The potentially serious nature of infection with E. coli O157:H7 is illustrated by the fact that about 6% of those infected individuals (particularly children) develop a sequela called the hemolytic uremic syndrome or HUS (2). The HUS is characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure, central nervous system involvement, and, in 3–5% of children, death (reviewed in ref.3). E. coli O157:H7 belongs to a subset of Shiga toxin-producing E. coli (STEC) named enterohemorrhagic E. coli (or EHEC) that not only make Shiga toxins (Stxs, formerly called Shiga-like toxins and alternatively known as verotoxins) but also attach to the bowel by a protein called intimin and evoke an attach and efface (A/E) lesion at the site of the bacterial-enterocyte interface (4). The pathogenic process by which E. coli O157:H7 and some other STEC evoke blood in the stools and cause the HUS and the adult version of HUS, thrombotic thrombocytopenic purpura (TTP), remains incompletely understood. Nevertheless, Stx appears to play a pivotal role in these manifestations, and endothelial cells are a primary target of Stx action (5,6). A number of animal species have been tried as models of STEC infection or Stx-mediated disease. However, in no single animal system is there replication of the entire spectrum of the infectious disease process as observed in humans (i.e., in humans, the steps in STEC pathogenesis include oral infection followed by diarrhea, sometimes HC, and occasionally the HUS). Nevertheless, there are animal models that mimic parts of the disease process. These models are described in the following subheadings, with the exception of pig and bovine models, which are described elsewhere in this volume. A summary of the animal types, treatments, and outcomes is given in Table 1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Centers for Disease Control and Prevention (1994) Addressing emerging infectious disease threats: a prevention strategy for the United States. MMWR 43, 1–18.
Griffin P. M. (1998) Epidemiology of Shiga toxin-producing Escherichia coli infections in humans in the United States, in Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains (Kaper J. B. and O’Brien A. D., eds.), ASM Washington, DC, pp. 15–22.
Griffin P. M. (1995) Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli, in Infections of the Gastrointestinal Tract (Blaser M. J., Smith P. D., Ravdin J. I., Greenberg H. B., and Guerrant R. L., eds.), Raven New York, pp 739–761.
Levine M. M. (1987) Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J. Infect. Dis. 155, 377–389.
Obrig T. G. (1998) Interaction of Shiga toxins with endothelial cells, in Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains (Kaper J. B. and O’Brien A. D., eds.), ASM Washington, DC, pp. 303–311.
Richardson S. E., Rotman T. A., Jay V., Smith C. R., Becker L. E., Petric M., et al. (1992) Experimental verocytotoxemia in rabbits. Infect. Immun. 60, 4154–4167.
Myhal M. L., Laux D. C., and Cohen P. S. (1982) Relative colonizing abilities of human fecal and K-12 strains of Escherichia coli in the large intestines of streptomycintreated mice. Eur. J. Clin. Microbiol. 1, 186–192.
Wadolkowski E. A., Burris J. A., and O’Brien A. D. (1990) Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 58, 2438–2445.
Wadolkowski E. A., Sung L. M., Burris J. A., Samuel J. E., and O’Brien A. D. (1990) Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect. Immun. 58, 3959–3965.
Kokai-Kun J. F., Melton-Celsa A. R., and O’Brien A. D. (2000) Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d. J. Biol. Chem. 275, 3713–3721.
Melton-Celsa A. R. and O’Brien A. D. (1996) Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect. Immun. 64, 1569–1576.
Edwards A. C., Melton-Celsa A. R., Arbuthnott K., Stinson J. R., Schmitt C. K., Wong H. C., et al. (1998) Vero cell neutralization and mouse protective efficacy of humanized monoclonal antibodies against Escherichia coli toxins Stx1 and Stx2, in Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains (Kaper J. B. and O’Brien A. D., eds.), ASM Washington DC, pp. 388–392.
Lindgren S. W., Melton A. R., and O’Brien A. D. (1993) Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect. Immun. 61, 3832–3842.
Zhang X., McDaniel A. D., Wolf L. E., Keusch G. T., Waldor M. K., and Acheson D. W. K. (2000) Quinolone antibiotics induce Shiga toxin encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 181, 664–670.
Fujii J., Kita T., Yoshida S.-I., Takeda T., Kobayashi H., Tanaka N., et al. (1994) Direct evidence of neuron impairment by oral infection with verotoxinproducing Escherichia coli O157:H-in mitomycin-treated mice. Infect. Immun. 62, 3447–3453.
Karpman D., Connell H., Svensson M., Scheutz F., Alm P., and Svanborg C. (1997) The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J. Infect. Dis. 175, 611–620.
Griffin P. M., Ostroff S. M., Tauxe R. V., Greene K. D., Wells J. G., Lewis J. H., et al. (1988) Illnesses associated with Escherichia coli O157:H7 infections. Ann. Intern. Med. 109, 705–712.
Kurioka T., Yunou Y., and Kita E. (1998) Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect. Immun. 66, 1726–1734.
Farmer J. J., III, Potter M. E., Riley L. W., Barrett T. J., Blake P. A., Cohen M. L., et al. (1983) Animal models to study Escherichia coli O157:H7 isolated from patients with haemorrhagic colitis [Letter]. Lancet 1, 702–703.
Pai C. H., Kelley J. K., and Meyers G. L. (1986) Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect. Immun. 51, 16–23.
Sjogren R., Neill R., Rachmilewitz D., Fritz D., Newland J., Sharpnack D., et al. (1994) Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. Gastroenterology 106, 306–317.
Sherman P., Soni R., and Karmali M. (1988) Attaching and effacing adherence of vero cytotoxin-producing Escherichia coli to rabbit intestinal epithelium in vivo. Infect. Immun. 56, 756–761.
O’Brien A. D. and LaVeck G. D. (1983) Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli. Infect. Immun. 40, 675–683.
Fujii J., Kinoshita Y., Kita T., Higure A., Takeda T., Tanaka N., et al. (1996) Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect. Immun. 64, 5053–5060.
Barrett T. J., Potter M. E., and Wachsmuth I. K. (1989) Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases. J. Infect. Dis. 159, 774–777.
Keenan K. P., Sharpnack D. D., Collins H., Formal S. B., and O’Brien A. D. (1986) Morphologic evaluation of the effects of Shiga toxin and E. coli Shiga-like toxin on the rabbit intestine. Am. J. Pathol. 125, 69–80.
Taylor F. B., Jr., Tesh V. L., DeBault L., Li A., Chang A. C. K., Kosanke S. D., et al. (1999) Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am. J. Pathol. 154, 1285–1299.
Kang G., Pulimood A., Mathan M., and Mathan V. I. (1997) A primate model of enterohemorrhagic Escherichia coli infection. 3rd International Symposium and Workshop on Shiga Toxin (Verocytotoxin)-Producing Escherichia coli Infections (VTEC’ 97), abstract V104/IV.
Beery J. T., Doyle M. P., and Schoeni J. L. (1985) Colonization of chicken cecae by Escherichia coli associated with hemorrhagic colitis. Appl. Environ. Microbiol. 49, 310–315.
Schoeni J. L. and Doyle M. P. (1994) Variable colonization of chickens perorally inoculated with Escherichia coli O157:H7 and subsequent contamination of eggs. Appl. Environ. Microbiol. 60, 2958–2962.
Sueyoshi M. and Nakazawa M. (1994) Experimental infection of young chicks with attaching and effacing Escherichia coli. Infect. Immun. 62, 4066–40
Fenwick B. W. and Cowan L. A. (1998) Canine model of the hemolytic uremic syndrome, in Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains. (Kaper J. B. and O’Brien A. D., eds.), ASM Washington, DC, pp. 268–277.
Petric M., Karmali M. A., Richardson S., and Cheung R. (1987) Purification and biological properties of Escherichia coli verocytotoxin. FEMS Microbiol. Lett. 41, 63–68.
Yutsudo T., Nakabayashi N., Hirayama T., and Takeda Y. (1987) Purification and some properties of a verotoxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. Microb. Pathol. 3, 21–30.
Downes F. P., Barrett T. J., Green J. H., Aloisio C. H., Spika J. S., Strockbine N. A., et al. (1988) Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies. Infect. Immun. 56, 1926–1933.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Melton-Celsa, A.R., O’Brien, A.D. (2003). Animal Models for STEC-Mediated Disease. In: Philpott, D., Ebel, F. (eds) E. coli. Methods in Molecular Medicine™, vol 73. Humana Press. https://doi.org/10.1385/1-59259-316-X:291
Download citation
DOI: https://doi.org/10.1385/1-59259-316-X:291
Publisher Name: Humana Press
Print ISBN: 978-0-89603-939-1
Online ISBN: 978-1-59259-316-3
eBook Packages: Springer Protocols